Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
3.530
+0.330 (10.31%)
At close: Apr 25, 2025, 4:00 PM
3.510
-0.020 (-0.57%)
After-hours: Apr 25, 2025, 4:19 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $10.73 million as of April 25, 2025. Its market cap has decreased by -53.32% in one year.
Market Cap
10.73M
Enterprise Value
7.76M
1-Year Change
-53.32%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $10.73M, a decrease of -81.68%. That is a compound annual growth rate of -38.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 10.73M | -26.29% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 790.64B |
| UnitedHealth Group | 380.75B |
| Johnson & Johnson | 369.92B |
| AbbVie | 329.98B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 222.77B |
| AstraZeneca | 215.41B |
| Novartis AG | 211.71B |